Highlights of the American College of Rheumatology 2010 Annual Scientific Meeting
The Latest Treatment Advances for Lupus
Treatment May Prevent Neonatal Lupus
The Brain and Lupus: 2010 Update
Risk of Some Cancers Double in Lupus
Assessing the Cost of Lupus
From the Lab to the Clinic: Lessons Learned About Lupus
ALR-Supported Research Focus of Plenary Session
The Alliance for Lupus Research Presents Highlights from the American College of Rheumatology Meeting, Atlanta, GA.
The Alliance for Lupus Research (ALR) is pleased to share our third annual American College of Rheumatology (ACR) Meeting Special Report. Each year, thousands of lupus researchers and clinicians from around the world gather at the ACR’s annual meeting to network and share their latest discoveries.
The 2010 ACR meeting was held in Atlanta in November. More than 15,000 scientists and physicians from over 100 countries attended the 5-day meeting. They heard presentations from more than 400 speakers and viewed thousands of posters, highlighting the latest work in rheumatologic diseases, including lupus.
We’ve focused on some of the most relevant presentations in this report, as well as several presentations by our grantees. As always, the most exciting news comes in the work on new therapies, like the drug Benylsta® (belimumab). We hope you find the information helpful and hopeful; we certainly think it is.
We look forward to sharing more information with you about lupus research and treatment advances in the months ahead. We thank our corporate sponsors, Biogen Idec, Genentech and Johnson & Johnson, for their generous support of this special report.
Executive Director, Alliance for Lupus Research
More information about lupus and treatment advances can be found by visiting www.lupusresearch.org.
The 2010 American College of Rheumatology Meeting Special Report was made possible in part by generous support from Biogen Idec, Genentech and Johnson & Johnson.
©2010 Alliance for Lupus Research. All Rights Reserved.
Contents herein may not be reproduced, republished or distributed without the prior written permission of the Alliance for Lupus Research. To request permission to reproduce, republish or distribute any part of this report, contact us at 212-218-2840 or email email@example.com.